$5.76
0.081.41%
À la fermeture: -
$5.68
-0.08-1.39%
Après les heures de négociation: Aug 29, 7:01 PM EDT
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Salarius Pharmaceuticals Inc (NASDAQ:SLRX) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 803.61K à 1.19M. Cela représente -% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Salarius Pharmaceuticals Corp (XNAS:SLRX) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 1.04M actions échangées par jour, il faudrait 1.14 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
1.19M
Intérêt à court terme %
–
Jours de couverture
1.14
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
SLRX | Salarius Pharmaceuticals, Inc. | 08/15/2025 | 08/26/2025 | — | 508,989 | 1,187,013 | 1,040,195 | 1.14 | |
SLRX | Salarius Pharmaceuticals, Inc. | 07/31/2025 | 08/11/2025 | 37.97% | 2,116,541 | 803,608 | 9,544,098 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 07/15/2025 | 07/24/2025 | 32.06% | 2,116,541 | 678,491 | 239,866 | 2.83 | |
SLRX | Salarius Pharmaceuticals, Inc. | 06/30/2025 | 07/10/2025 | 33.35% | 2,116,541 | 705,803 | 7,020,149 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 06/13/2025 | 06/25/2025 | 1.48% | 2,116,541 | 31,420 | 55,681 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 05/30/2025 | 06/10/2025 | 2.27% | 2,116,541 | 47,988 | 18,357 | 2.61 | |
SLRX | Salarius Pharmaceuticals, Inc. | 05/15/2025 | 05/27/2025 | 2.49% | 2,116,541 | 52,652 | 35,063 | 1.5 | |
SLRX | Salarius Pharmaceuticals, Inc. | 04/30/2025 | 05/09/2025 | 3.98% | 2,116,541 | 84,158 | 46,307 | 1.82 | |
SLRX | Salarius Pharmaceuticals, Inc. | 04/15/2025 | 04/25/2025 | 5.34% | 2,116,541 | 112,934 | 415,960 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 03/31/2025 | 04/09/2025 | 8.05% | 1,717,250 | 138,176 | 654,925 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 03/14/2025 | 03/25/2025 | 2.35% | 1,717,250 | 40,435 | 42,906 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 02/28/2025 | 03/11/2025 | 5.45% | 1,572,822 | 85,721 | 362,710 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 02/14/2025 | 02/26/2025 | 0.66% | 1,572,822 | 10,411 | 74,551 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 01/31/2025 | 02/11/2025 | 1.23% | 1,572,822 | 19,341 | 338,181 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 01/15/2025 | 01/27/2025 | 19.82% | 1,572,822 | 311,722 | 13,592,213 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 12/31/2024 | 01/10/2025 | 2.18% | 1,430,412 | 31,114 | 136,273 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 12/13/2024 | 12/24/2024 | 1.84% | 1,430,412 | 26,336 | 31,848 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 11/29/2024 | 12/10/2024 | 2.54% | 1,430,412 | 36,355 | 29,162 | 1.25 | |
SLRX | Salarius Pharmaceuticals, Inc. | 11/15/2024 | 11/26/2024 | 3.84% | 1,430,412 | 54,982 | 31,099 | 1.77 | |
SLRX | Salarius Pharmaceuticals, Inc. | 10/31/2024 | 11/11/2024 | 4.55% | 1,430,413 | 65,040 | 873,513 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 10/15/2024 | 10/24/2024 | 0.11% | 1,430,413 | 1,528 | 752,486 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 09/30/2024 | 10/09/2024 | 1.05% | 1,430,413 | 15,020 | 74,925 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 09/13/2024 | 09/24/2024 | 0.66% | 1,430,413 | 9,397 | 55,567 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 08/30/2024 | 09/11/2024 | 1.07% | 1,430,413 | 15,326 | 153,594 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 07/31/2024 | 08/09/2024 | 14.72% | 586,310 | 86,315 | 10,529,352 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 07/15/2024 | 07/24/2024 | 10.22% | 586,310 | 59,939 | 249,670 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 06/28/2024 | 07/10/2024 | 3.24% | 586,310 | 18,969 | 94,444 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 06/14/2024 | 06/26/2024 | 5.44% | 586,310 | 31,873 | 67,416 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 05/31/2024 | 06/11/2024 | 0.58% | 4,690,483 | 27,295 | 23,906 | 1.14 | |
SLRX | Salarius Pharmaceuticals, Inc. | 05/15/2024 | 05/24/2024 | 0.71% | 4,690,483 | 33,483 | 35,250 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 04/30/2024 | 05/09/2024 | 1.57% | 4,690,483 | 73,617 | 22,872 | 3.22 | |
SLRX | Salarius Pharmaceuticals, Inc. | 04/15/2024 | 04/24/2024 | 2.46% | 4,690,483 | 115,612 | 50,870 | 2.27 | |
SLRX | Salarius Pharmaceuticals, Inc. | 03/28/2024 | 04/09/2024 | 6.36% | 4,228,135 | 268,900 | 616,904 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 03/15/2024 | 03/26/2024 | 0.37% | 3,852,135 | 14,387 | 25,879 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 02/29/2024 | 03/11/2024 | 0.47% | 3,852,135 | 18,010 | 37,271 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 01/31/2024 | 02/09/2024 | 0.21% | 3,852,135 | 8,255 | 23,401 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 01/12/2024 | 01/24/2024 | 0.16% | 3,852,135 | 6,078 | 38,779 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 12/29/2023 | 01/10/2024 | 0.25% | 3,852,135 | 9,698 | 40,893 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 12/15/2023 | 12/27/2023 | 0.18% | 3,852,135 | 6,968 | 33,453 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 11/30/2023 | 12/11/2023 | 0.65% | 3,852,135 | 24,866 | 36,578 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 11/15/2023 | 11/27/2023 | 1.47% | 3,852,135 | 56,634 | 37,080 | 1.53 | |
SLRX | Salarius Pharmaceuticals, Inc. | 10/31/2023 | 11/09/2023 | 2.06% | 3,555,135 | 73,210 | 41,788 | 1.75 | |
SLRX | Salarius Pharmaceuticals, Inc. | 10/13/2023 | 10/24/2023 | 0.87% | 3,555,135 | 30,909 | 176,375 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 09/29/2023 | 10/10/2023 | 0.54% | 3,555,135 | 19,033 | 16,700 | 1.14 | |
SLRX | Salarius Pharmaceuticals, Inc. | 09/15/2023 | 09/26/2023 | 0.57% | 3,555,135 | 20,340 | 34,586 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 08/31/2023 | 09/12/2023 | 0.78% | 3,555,135 | 27,591 | 20,657 | 1.34 |
À la recherche des actions les plus vendues à découvert?